Search filters

List of works by William K. Oh

A Phase II trial of flavopiridol (NSC #649890) in patients with previously untreated metastatic androgen-independent prostate cancer

scientific article published in February 2004

A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy

scientific article published on 01 March 2011

A multi-institutional phase II trial of gemcitabine plus paclitaxel in patients with locally advanced or metastatic urothelial cancer

scientific article published in September 2004

A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone-refractory prostate cancer who are refractory to docetaxel

scientific article

A phase II study of estramustine, docetaxel, and carboplatin with granulocyte-colony-stimulating factor support in patients with hormone-refractory prostate carcinoma: Cancer and Leukemia Group B 99813.

scientific article

A phase II study of mifepristone (RU-486) in castration-resistant prostate cancer, with a correlative assessment of androgen-related hormones.

scientific article published in May 2008

A phase II trial of interferon-alpha and toremifene in advanced renal cell cancer patients

scientific article published in January 2002

A retrospective evaluation of second-line chemotherapy response in hormone-refractory prostate carcinoma: second line taxane-based therapy after first-line epothilone-B analog ixabepilone (BMS-247550) therapy.

scientific article published in January 2006

A whole-blood RNA transcript-based prognostic model in men with castration-resistant prostate cancer: a prospective study

scientific article published on 9 October 2012

Absence of relationship between steroid hormone levels and prostate cancer tumor grade

scientific article published on 26 November 2008

Accelerating precision medicine in metastatic prostate cancer

scientific article published on 17 November 2020

Activity of dutasteride plus ketoconazole in castration-refractory prostate cancer after progression on ketoconazole alone

scientific article published in October 2009

Activity of ketoconazole after taxane-based chemotherapy in castration-resistant prostate cancer

scientific article published on 23 October 2009

Activity of the herbal combination, PC-SPES, in the treatment of patients with androgen-independent prostate cancer

article

Analysis of the 10q11 cancer risk locus implicates MSMB and NCOA4 in human prostate tumorigenesis

scientific article

Angiogenesis inhibitor therapies for metastatic renal cell carcinoma: effectiveness, safety and treatment patterns in clinical practice-based on medical chart review.

scientific article published on 26 October 2009

Application of oligonucleotide microarrays to assess the biological effects of neoadjuvant imatinib mesylate treatment for localized prostate cancer

scientific article published in January 2006

Arterial thromboembolism in cancer patients treated with cisplatin: a systematic review and meta-analysis

scientific article published on 23 October 2012

Atypical metastases from prostate cancer: 10-year experience at a single institution

scientific article published on August 2012

Bevacizumab treatment of prostate cancer

scientific article published on 09 July 2012

CD44 expression is a feature of prostatic small cell carcinoma and distinguishes it from its mimickers

scientific article published on 05 October 2008

Cabazitaxel

scientific article published on September 2010

Cancer therapy from bench to bedside

scientific article published on 01 November 2010

Carbonic anhydrase IX and pathological features as predictors of outcome in patients with metastatic clear-cell renal cell carcinoma receiving vascular endothelial growth factor-targeted therapy

scientific article published on 2 March 2010

Carboplatin for Stage I Seminoma

article

Castration-resistant prostate cancer: AUA Guideline

scientific article published on 09 May 2013

Celecoxib versus placebo for men with prostate cancer and a rising serum prostate-specific antigen after radical prostatectomy and/or radiation therapy

scientific article published on June 2006

Cisplatin-based combination chemotherapy in septuagenarians with metastatic urothelial cancer ⬇️

scientific article published on February 18, 2013

Clinical Development of Cabazitaxel for the Treatment of Castration-Resistant Prostate Cancer ⬇️

scientific article published on May 24, 2011

Clinical development of novel therapeutics for castration-resistant prostate cancer: historic challenges and recent successes

scientific article published on 24 April 2012

Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma

scientific article published on 4 May 2011

Complementary and alternative therapies in prostate cancer.

scientific article

Cost implications of IV versus oral anti-angiogenesis therapies in patients with advanced renal cell carcinoma: retrospective claims database analysis.

scientific article published in August 2009

Department of Defense prostate cancer clinical trials consortium: a new instrument for prostate cancer clinical research.

scientific article

Development of an integrated prostate cancer research information system.

scientific article

Dilemmas and controversies in the management of prostate cancer continue to present a vexing challenge to physicians and patients dealing with the disease. Preface

scientific article published on 01 February 2010

Distinct prognostic role of prostate-specific antigen doubling time and velocity at emergence of androgen independence in patients treated with chemotherapy

scientific article published on September 2007

Docetaxel chemotherapy remains the standard of care in castration-resistant prostate cancer

scientific article published on 22 July 2008

Does oral antiandrogen use before leuteinizing hormone-releasing hormone therapy in patients with metastatic prostate cancer prevent clinical consequences of a testosterone flare?

scientific article

Dynamic change in phosphorylated platelet-derived growth factor receptor in peripheral blood leukocytes following docetaxel therapy predicts progression-free and overall survival in prostate cancer.

scientific article published on 07 October 2008

Efficacy of androgen deprivation therapy (ADT) in patients with advanced prostate cancer

article

Efficacy of carboplatin-taxane combinations in the management of castration-resistant prostate cancer: a pooled analysis of seven prospective clinical trials

scientific article

Efficacy of nilutamide as secondary hormonal therapy in androgen-independent prostate cancer

scientific article

Elevated plasma tissue inhibitor of metalloproteinase-1 levels predict decreased survival in castration-resistant prostate cancer patients

scientific article published on 22 September 2010

Emerging personalized approaches for the management of advanced urothelial carcinoma

scientific article published on December 2012

Evaluation of 8q24 and 17q risk loci and prostate cancer mortality

scientific article

Evaluation of the 8q24 prostate cancer risk locus and MYC expression.

scientific article

Failure of gonadotropin-releasing hormone agonists with and without sterile abscess formation at depot sites: insight into mechanisms?

scientific article published on 01 May 2006

Finasteride and flutamide therapy in patients with advanced prostate cancer: response to subsequent castration and long-term follow-up

scientific article published in July 2003

Functional enhancers at the gene-poor 8q24 cancer-linked locus.

scientific article published on 14 August 2009

Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21.

scientific article

Genome-wide association study of prostate cancer mortality

scientific article

Germline CAG repeat length of the androgen receptor and time to progression in patients with prostate cancer treated with androgen deprivation therapy.

scientific article published on 16 March 2011

High-risk localized prostate cancer: integrating chemotherapy

scientific article published in October 2005

Higher prostate-specific antigen levels predict improved survival in patients with hormone-refractory prostate cancer who have skeletal metastases and normal serum alkaline phosphatase

scientific article published on 01 December 2007

Identification of microR-106b as a prognostic biomarker of p53-like bladder cancers by ActMiR

scientific article published on 03 July 2018

Impact of the CKD-EPI equation for estimating renal function on eligibility for cisplatin-based chemotherapy in patients with urothelial cancer

scientific article published on 29 November 2011

Inherited variants in the chemokine CCL2 gene and prostate cancer aggressiveness in a Caucasian cohort

scientific article published on 6 December 2010

Initial decline in hemoglobin during neoadjuvant hormonal therapy predicts for early prostate specific antigen failure following radiation and hormonal therapy for patients with intermediate and high-risk prostate cancer

scientific article

Is there a role for platinum chemotherapy in the treatment of patients with hormone-refractory prostate cancer?

scientific article published on February 2007

Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular cancer: a long-term update.

scientific article

Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019

scientific article published on 27 January 2020

Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017.

scientific article

Management of hormone refractory prostate cancer: current standards and future prospects ⬇️

scientific article published on October 1, 1998

Metabolic and toxicological considerations of newly approved prostate cancer drugs

scientific article published on 12 April 2013

Multi-institutional randomized phase II trial of the epothilone B analog ixabepilone (BMS-247550) with or without estramustine phosphate in patients with progressive castrate metastatic prostate cancer.

scientific article published in March 2005

Neoadjuvant docetaxel followed by radical prostatectomy in patients with high-risk localized prostate cancer: a preliminary report

scientific article published on August 2001

Neoadjuvant doxil chemotherapy prior to androgen ablation plus radiotherapy for high-risk localized prostate cancer: feasibility and toxicity

scientific article published on June 2003

Neoadjuvant therapy before radical prostatectomy in high-risk localized prostate cancer: defining appropriate endpoints.

scientific article

New paradigms in microtubule-mediated endocrine signaling in prostate cancer

scientific article published on May 2013

Nomogram for predicting survival in patients with unresectable and/or metastatic urothelial cancer who are treated with cisplatin‐based chemotherapy ⬇️

scientific article published on May 29, 2013

Overcoming castration resistance in prostate cancer

scientific article published on May 2012

Overtreatment of a patient with presumed recurrent prostate cancer based on false-positive prostate specific antigen results

scientific article published on 01 October 2003

Overview consensus statement. Newer approaches to androgen deprivation therapy in prostate cancer

scientific article

PC-SPES and prostate cancer

scientific article published on 01 February 2002

PC3 is a cell line characteristic of prostatic small cell carcinoma.

scientific article

Phase I study of the effects of renal impairment on the pharmacokinetics and safety of satraplatin in patients with refractory solid tumors.

scientific article

Phase II Study of Low Dose and High Dose Conjugated Estrogen for Androgen Independent Prostate Cancer

article

Phase II study of sunitinib in men with advanced prostate cancer.

scientific article

Phase II trial of RAD001 and bicalutamide for castration-resistant prostate cancer

scientific article published on 29 August 2012

Photoluminescent polymer nanoparticles for label-free cellular imaging

scientific article published on 22 June 2010

Physician attitudes toward cytotoxic chemotherapy use in patients with advanced prostate carcinoma

scientific article published in May 2003

Platelet-derived growth factor receptor inhibition and chemotherapy for castration-resistant prostate cancer with bone metastases

scientific article published in October 2007

Predicting outcome in localized prostate cancer: how far have we come?

scientific article published on 01 June 2003

Predictors of survival in patients with prostate cancer and spinal metastasis. Presented at the 2009 Joint Spine Section Meeting. Clinical article

scientific article

Prevalence and characteristics of patients with metastatic cancer who receive no anticancer therapy

scientific article

Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study

scientific article

Progressive sclerosis of isolated foot metastasis of prostate cancer

scientific article published on 01 March 2002

Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer.

scientific article

Prostate cancer risk associated loci in African Americans

scientific article published on 23 June 2009

Quality of care for older patients with cancer in the Veterans Health Administration versus the private sector: a cohort study

scientific article published in June 2011

Radical prostatectomy lowers plasma vascular endothelial growth factor levels in patients with prostate cancer

scientific article published in February 2004

Randomized phase II study of atrasentan alone or in combination with zoledronic acid in men with metastatic prostate cancer

scientific article published on 01 August 2006

Rapid rise of serum prostate specific antigen levels after discontinuation of the herbal therapy PC-SPES in patients with advanced prostate carcinoma: report of four cases.

scientific article published in February 2002

Recent progress in hormonal therapy for advanced prostate cancer.

scientific article

Recurrence-free survival in prostate cancer is related to increased stromal TRAIL expression.

scientific article

Relationship between 6‐ and 9‐month progression‐free survival and overall survival in patients with metastatic urothelial cancer treated with first‐line cisplatin‐based chemotherapy ⬇️

scientific article published on May 29, 2013

Relationship between serum adiponectin and prostate cancer grade.

scientific article

Response to docetaxel/carboplatin-based chemotherapy as first- and second-line therapy in patients with metastatic hormone-refractory prostate cancer

scientific article

Response to low-dose ketoconazole and subsequent dose escalation to high-dose ketoconazole in patients with androgen-independent prostate cancer

scientific article published on 01 September 2006

Response to second-line chemotherapy in patients with hormone refractory prostate cancer receiving two sequences of mitoxantrone and taxanes

scientific article published on 01 June 2006

Response to vinorelbine with or without estramustine as second-line chemotherapy in patients with hormone-refractory prostate cancer

scientific article published on 01 March 2007

Retrospective Analysis of Satraplatin in Patients with Metastatic Urothelial Cancer Refractory to Standard Platinum-Based Chemotherapy

scientific article published on 22 June 2011

Risk of venous thromboembolism in patients with cancer treated with Cisplatin: a systematic review and meta-analysis.

scientific article

Rosiglitazone versus placebo for men with prostate carcinoma and a rising serum prostate-specific antigen level after radical prostatectomy and/or radiation therapy

scientific article published in October 2004

SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer

scientific article

Secondary Hormonal Therapy in Men With Castration-Resistant Prostate Cancer

article

Secondary hormonal therapies in the treatment of prostate cancer.

scientific article

Selective aromatase inhibition for patients with androgen-independent prostate carcinoma

scientific article published in November 2002

Selective cell death mediated by small conditional RNAs: a novel therapeutic approach to cancer therapy

scientific article published on 15 November 2010

Single-nucleotide polymorphisms in p53 pathway and aggressiveness of prostate cancer in a Caucasian population.

scientific article

Sixty years of CA: a cancer journal for clinicians

scientific article

Smoking and alcohol use may be risk factors for poorer outcome in patients with clear cell renal carcinoma.

scientific article

Surrogate endpoints for overall survival for patients with metastatic hormone-sensitive prostate cancer in the CHAARTED trial

scientific article published on 20 April 2020

Targeting the androgen receptor signalling axis in castration-resistant prostate cancer (CRPC).

scientific article published on 18 September 2012

The Impact of Gender on Outcomes in Patients With Metastatic Urothelial Carcinoma ⬇️

scientific article published on May 11, 2013

The emerging role of circulating tumor cell detection in genitourinary cancer

scientific article published on 12 May 2012

The evolving role of chemotherapy and other systemic therapies for managing localized prostate cancer.

scientific article published on December 2003

The impact of common genetic variations in genes of the sex hormone metabolic pathways on steroid hormone levels and prostate cancer aggressiveness

scientific article published on 7 September 2011

The mechanism of action of estrogen in castration-resistant prostate cancer: clues from hormone levels

scientific article published in October 2009

The medical management of prostate cancer: a multidisciplinary team approach.

scientific article published on 6 September 2006

The risk of renal impairment in hormone-refractory prostate cancer patients with bone metastases treated with zoledronic acid.

scientific article published on March 2007

The role of ketoconazole in current prostate cancer care

article

Time to prostate-specific antigen nadir independently predicts overall survival in patients who have metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy

scientific article published on March 2009

Treatment of a radiation-induced rectal ulcer with hyperbaric oxygen therapy in a man with prostate cancer

scientific article published on 01 November 2006

Treatment of bicalutamide-induced gynecomastia with breast-reduction surgery in prostate cancer.

scientific article

Treatment of patients with metastatic urothelial cancer "unfit" for Cisplatin-based chemotherapy.

scientific article published on 09 May 2011

Treatment-related mortality with vascular endothelial growth factor receptor tyrosine kinase inhibitor therapy in patients with advanced solid tumors: a meta-analysis

scientific article published on 30 May 2012

Trends in the use of cytoreductive nephrectomy in the United States

scientific article published on 30 May 2012

Tumour angiogenesis: an elusive target in castration-resistant prostate cancer

scientific article published on 4 June 2013

Urological cancer: Enzalutamide in metastatic CRPC-old dog, new tricks

scientific article published on 09 October 2012

Use of androgen deprivation therapy for metastatic prostate cancer in older men.

scientific article

Vinorelbine and estramustine in androgen-independent metastatic prostate cancer: a phase II study

scientific article published in October 2000

What is the current status of second-line chemotherapy for castration-resistant prostate cancer?

scientific article published on 21 October 2008

Paulina is supported by:

About Paulina

Help